Addiction Medicine Certification Treatment Planning & Protocols 5

Question 1

A patient with opioid use disorder on buprenorphine/naloxone develops new-onset severe hepatitis C. How should this affect the treatment plan?

Accepted Answer

Continue buprenorphine while treating HCV concurrently, as buprenorphine is safe and HCV treatment improves outcomes

Answer

Buprenorphine is safe in HCV patients, and direct-acting antiviral therapy should proceed concurrently; treating both together improves overall outcomes.

Question 2

Which element is essential when documenting a comprehensive addiction treatment plan to meet ASAM and regulatory standards?

Accepted Answer

Individualized goals, measurable objectives, identified services, and anticipated treatment duration

Answer

An ASAM-compliant treatment plan must include individualized, measurable goals and objectives, identified interventions, and expected timelines.

Question 3

A 45-year-old patient with alcohol use disorder reports taking metronidazole for a dental infection. The patient asks if it is safe to drink a small amount of alcohol at a family event. What is the most accurate counseling?

Accepted Answer

Alcohol should be completely avoided; metronidazole can cause a disulfiram-like reaction with any amount of alcohol

Answer

Metronidazole inhibits aldehyde dehydrogenase and can produce a disulfiram-like reaction (flushing, nausea, vomiting, tachycardia) with any alcohol consumption.

Question 4

In motivational interviewing, which clinician behavior is most consistent with the 'spirit' of MI when responding to patient ambivalence about treatment?

Accepted Answer

Using reflective listening to explore and amplify the patient's own arguments for change

Answer

MI's spirit involves evoking the patient's own motivation through reflective listening and open-ended questions, not persuasion or coercion.

Question 5

Which of the following best describes the Low-Dose Induction (Bernese method) of buprenorphine initiation?

Accepted Answer

Gradually increasing buprenorphine doses over several days while the patient continues to use full-agonist opioids, avoiding precipitated withdrawal

Answer

The Bernese (microdosing) induction allows buprenorphine to be started in very small escalating doses alongside continued opioid use, preventing precipitated withdrawal.

Addiction Medicine Certification Practice Test

Addiction Medicine Certification Practice Test

Addiction Medicine Certification Treatment Planning & Protocols 5